Circle Internet Group could ironically be under pressure after the passing of key crypto legislation, according to Compass Point. Analyst Ed Engle lowered his rating on the USDC stablecoin manager to sell from neutral and cut his price target on the stock $130 from $205. The new forecast implies downside of 40% from Monday’s close. President Donald Trump on Friday signed into law the GENIUS Act, a piece of legislation dedicated to regulating stablecoins. But while this legislation is a positive for the crypto industry, Engle believes it will Circle will be under pressure in the short term. “While we…
Author: usaeverydaylife
A 12-pack of Coca-Cola is displayed on a counter in a 7-Eleven convenient store in Austin, Texas, on July 17, 2025.Brandon Bell | Getty ImagesCoca-Cola on Tuesday reported quarterly earnings and revenue that topped analysts’ expectations as strong demand in Europe offset weaker volume in other markets.Shares of the company fell less than 1% in premarket trading.Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:Earnings per share: 87 cents adjusted vs. 83 cents expectedRevenue: $12.62 billion adjusted vs. $12.54 billion expectedCoke reported second-quarter net income attributable to shareholders of…
UBS is going all in when it comes to Albertsons . The bank upgraded shares of the grocery store chain to a buy rating from neutral. Analyst Mark Carden raised his 12-month price target to $27 per share from $22, implying upside ahead of 35%. UBS’ rating change comes after a 7% drop this month. ACI mountain 2025-07-01 ACI in July “ACI’s recent pullback doesn’t fully reflect 1) its top line opportunity from pharmacy cross-shopping & digital, 2) its profitability opportunities from centralizing buying & retail media, & 3) its footprint-driven competitive advantages,” Carden wrote. “It’s already lowered expectations for…
President Donald Trump attends a bilateral meeting with European Commission President Ursula von der Leyen during the 50th World Economic Forum (WEF) annual meeting in Davos, Switzerland, January 21, 2020.Jonathan Ernst | ReutersThe European Union appears to be preparing to deploy its “Anti-Coercion Instrument” — characterized as a “nuclear option” to try to deter trade disputes — as the threat of a 30% tariff on EU imports looms large.A number of EU member states, including France and Germany, are reportedly considering using “anti-coercion” measures targeting the U.S. if the bloc cannot reach a trade deal with U.S. President Donald Trump, EU diplomats…
A study of affluent Chinese released this month by consulting firm Oliver Wyman found that 22% of respondents were negative about the economy when surveyed in May. It just exceeds the 21% seen in October 2022, just before Beijing announced plans to ease its stringent zero-Covid policy.Dukai Photographer | Moment | Getty ImagesBEIJING — China’s affluent are feeling just as poorly about the economy as they did during the pandemic.That’s according to a study of affluent Chinese released this month by consulting firm Oliver Wyman, which found 22% of respondents were negative about the economy when surveyed in May. It…
U.S. President Donald Trump (L) listens as Nvidia CEO Jensen Huang speaks in the Cross Hall of the White House during an event on “Investing in America” on April 30, 2025 in Washington, DC.Andrew Harnik | Getty ImagesThe China-U.S. trade war in the first Donald Trump administration saw Apple CEO Tim Cook go on a charm offensive with the president while maintaining strong relations with Beijing. Apple avoided U.S. tariffs and continued to grow in China, while Cook earned the reputation as a skilled policy navigator and prominent American business envoy to Beijing.But, in Trump 2.0, not only has Apple…
Orange juice prices could rise by 20% to 25%, according to Johanna Foods, a small U.S. business suing the White House over tariffs threatened against Brazil.President Donald Trump said in a July 9 letter to President Luiz Inacio Lula da Silva that he would apply a 50% tariff to all imports from Brazil starting Aug. 1.Trump said the high tariff rate was necessary because of “the way Brazil has treated former President Bolsonaro.”Prosecutors in Brazil have alleged that Bolsonaro was part of a scheme that included a plan to assassinate the country’s current president, who defeated him in the last election, and Supreme Federal…
Thailand’s cabinet on Tuesday gave its approval for Vitai Ratanakorn to be the next governor of the Bank of Thailand, a government official said.Bloomberg | Bloomberg | Getty ImagesThailand’s cabinet on Tuesday gave its approval for Vitai Ratanakorn to be the next governor of the Bank of Thailand, a government official said.The appointment of Vitai, 54, the president and CEO of the Government Savings Bank, would be subject to royal approval before he starts a five-year term on October 1. The cabinet approval was announced by government spokesperson Jirayu Huangsap.Vitai will succeed Sethaput Suthiwartnarueput, who could not seek a second term as he has reached…
Open AI CEO Sam Altman speaks during Snowflake Summit 2025 at Moscone Center on June 02, 2025 in San Francisco, California. Justin Sullivan | Getty ImagesOpenAI said it will open its first office in Washington, D.C. early next year, the latest sign that the artificial intelligence startup is looking to deepen its ties to lawmakers and and regulators. The office will be home to OpenAI’s workforce in the nation’s capital, which is currently made up of about 30 people, an OpenAI spokesperson said Monday. The company has been operating out of a co-working space in the city for the past…
The office building of international biopharmaceutical company AstraZeneca.Cfoto | Future Publishing | Getty ImagesAstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs.The Anglo-Swedish biotech company, which is headquartered in Cambridge, England, said the “cornerstone” of the commitment would be a new multi-billion dollar facility to produce its weight management and metabolic portfolio, including its oral GLP-1 obesity pill.The facility, planned for the Commonwealth of Virginia, is set to be AstraZeneca’s largest…
